Sars-cov Infection
📧 Sign up to get email alerts when something new happens for Sars-cov Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Efficacy of the Sit to Stand Test in the Decision to Hospitalize a Patient Consulting the Emergency Dept for COVID 19 [NA]
Update on a terminated clinical trial investigating whether the sit-to-stand test can aid hospitalization decisions for emergency department…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of Concept
A completed study investigates a portable, connected biosensor for rapid detection of SARS-CoV-2/COVID-19 as a biological proof of concept.
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: COVID-19 IgG Formation in Physicians at ALGH and Their Household Members
Clinical trial update on COVID-19 IgG formation in physicians at ALGH and their household members; the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE) [Phase 4]
Phase 4 clinical trial update on the ENFORCE national cohort assessing effectiveness and safety of SARS-CoV-2/COVID-19 vaccines.
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine [Phase 1, Phase 2]
Phase 1/2 trial assessing reactogenicity, safety, and immunogenicity of the QazCoVac-P COVID-19 vaccine.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: Camostat With Bicalutamide for COVID-19 [Phase 1]
Phase 1 trial of camostat with bicalutamide for COVID-19 was terminated; results were posted in 2023.
-
CLINICAL_TRIALS withdrawal · 2023-07-25Clinical Trial Update: LIBERATE Trial in COVID-19 [Phase 4]
A Phase 4 clinical trial (LIBERATE) investigating COVID-19 has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations [Phase 2]
This Phase 2 clinical trial update reports systemic allergic reactions related to SARS-CoV-2 vaccinations, with results posted in June 2023.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study [Phase 3]
Phase 3 trial update for VERU-111 in SARS-CoV infection assessing mortality reduction; study completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2023-03-03Clinical Trial Update: Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19) [Phase 2, Phase 3]
A clinical trial evaluating hypochlorous acid prophylaxis for health personnel at high risk of SARS-CoV-2 infection has been withdrawn durin…
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection? [Phase 3]
Phase 3 clinical trial assessing whether losartan and other ARBs influence outcomes in coronavirus infection, terminated.
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Sargramostim Use in COVID-19 to Recover Patient Health [Phase 2]
A Phase 2 trial evaluating sargramostim for recovery in COVID-19 patients has completed with results posted in early 2023.
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: The DAWN Antivirals Trial for Ambulatory COVID-19 Patients [Phase 3]
Phase 3 trial update for the DAWN Antivirals Trial in ambulatory COVID-19 patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19 [Phase 3]
Phase 3 clinical trial update for CONVINCE evaluating edoxaban and colchicine for COVID-19, currently terminated.
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 [Phase 3]
A Phase 3 clinical study evaluating the effect of CimetrA in patients diagnosed with COVID-19 is listed, with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19 [Phase 2]
Phase 2 trial comparing oral ribavirin and nitazoxamide versus placebo in COVID-19/SARS-CoV infection has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: COVID-19 Prophylaxis South Africa (COVER HCW) [Phase 2]
Phase 2 clinical trial update on COVID-19 prophylaxis for healthcare workers in South Africa (COVER HCW) completed.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-05-05Clinical Trial Update: A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19 [Phase 2]
Phase 2 trial update for TriACT, a triple combination antiviral therapy for COVID-19, terminated with posted results in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Losartan for Patients With COVID-19 Not Requiring Hospitalization [Phase 2]
Phase 2 trial update examining losartan for non-hospitalized COVID-19 patients; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19 [Phase 2]
A randomized Phase IIA trial evaluated ivermectin for achieving negative PCR results in early-phase COVID-19 patients; the study is complete…
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19 [Phase 2]
Phase 2 clinical trial update for Glenzocimab in SARS-CoV-2–associated acute respiratory distress syndrome (COVID-19).
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: The Containing Coronavirus Disease 19 (COVID-19) Trial [Phase 3]
Phase 3 clinical trial for a COVID-19 related intervention completed; results not described in the provided snippet.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection [Phase 2]
Phase 2 trial evaluating chloroquine diphosphate for prevention of COVID-19/SARS-CoV infection has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 [Phase 2]
Phase 2 trial of chloroquine diphosphate for severe acute respiratory syndrome (SARS) due to SARS-CoV2 has completed.